NCT06015412

Brief Summary

To investigate the extent to which pain, functionality, and quality of life change over the progression of osteoarthritis grades.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
161

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 21, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 29, 2023

Completed
Last Updated

August 29, 2023

Status Verified

August 1, 2023

Enrollment Period

6 months

First QC Date

August 21, 2023

Last Update Submit

August 23, 2023

Conditions

Outcome Measures

Primary Outcomes (4)

  • Visual Analog Scale (VAS)

    a 10-cm straight line with 0 on one end indicating no pain and 10 on the other end signifying unbearable pain. The participants were asked to mark the intensity of their current pain on the line

    2 minutes

  • two-minute walk test (2MWT)

    A 45-meter corridor was used for the 2MWT. The start and end points were marked, and the participants were asked to walk at a normal pace within these boundaries. The distance covered in two minutes was recorded

    2 minutes

  • Western Ontario and McMaster Universities Osteoarthritis Index

    The questionnaire consists of 24 items, each scored from 0 to 4. The total score is obtained by summing the point equivalents of the responses given to all items. A higher score indicates poorer functionality

    10 minutes

  • Nottingham Health Profile (NHP)

    This tool comprises 38 questions in six domains, namely energy, pain, social isolation, physical mobility, emotional reactions, and sleep. Each domain is scored from 0 to 100. The total score is obtained by summing the scores obtained from the six domains. High scores indicate a good quality of life.

    10 minutes

Study Arms (4)

Grade 1 osteoarthritis

disease stages 1 according to the Kellgren-Lawrence radiographic classification system

Diagnostic Test: Radiographic classification

Grade 2 osteoarthritis

disease stages 2 according to the Kellgren-Lawrence radiographic classification system

Diagnostic Test: Radiographic classification

Grade 3 osteoarthritis

disease stages 3 according to the Kellgren-Lawrence radiographic classification system

Diagnostic Test: Radiographic classification

Grade 4 osteoarthritis

disease stages 4 according to the Kellgren-Lawrence radiographic classification system

Diagnostic Test: Radiographic classification

Interventions

disease stages ranged from 1 to 4 according to the Kellgren-Lawrence radiographic classification system

Grade 1 osteoarthritisGrade 2 osteoarthritisGrade 3 osteoarthritisGrade 4 osteoarthritis

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

diagnosed with the same grade of knee OA in both knees by the responsible physician in the hospital

You may qualify if:

  • having the same OA grade in both knees
  • volunteering to participate in the study
  • not having undergone previous lower extremity surgery

You may not qualify if:

  • neurological disorders;
  • those with a history of surgery related to the lower extremities;
  • those with orthopedic problems in the lower extremities, such as tendinopathy and bursitis;
  • those who had neurological, orthopedic, or cognitive disorders that would prevent walking;
  • those with a diagnosis of diabetes, obesity, or rheumatological disorders;
  • those who had received intra-articular injection therapy within the last three months;
  • and those with malignancy or perception problems.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Selcuk University

Konya, Selçuklu, 42130, Turkey (Türkiye)

Location

MeSH Terms

Conditions

OsteoarthritisPain

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Asst. Prof

Study Record Dates

First Submitted

August 21, 2023

First Posted

August 29, 2023

Study Start

November 1, 2022

Primary Completion

May 1, 2023

Study Completion

July 1, 2023

Last Updated

August 29, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations